Evolus, Inc. (EOLS) Earnings Call Analysis
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Next earnings call: 2026-08-05
(Q2 2026)
— full calendar
Earnings Reports
-
EOLS Q1 2026: Evelis Rewards Membership Surges 27%, Accelerating Platform Engagement
June 16, 2026
-
EOLS Q2 2025: Evelisse Launch Drives 10%–12% Revenue Contribution Amid Toxin Market Downturn
June 16, 2026
-
Evalyst (EOLS) Q3 2025: Evelisse Debut Drives 13% Revenue Lift, Sets Stage for Portfolio Bundling
June 16, 2026
-
Evolus (EOLS) Q4 2025: International Revenue Doubles, Portfolio Rebates Drive U.S. Share Gains
June 15, 2026
-
Evolus (EOLS) Q1 2025: Market Share Rises to 15% as Multi-Product Launch Accelerates Growth Path
July 04, 2025